You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-EGFR-PD158780
PD158780

Chemical Structure : PD158780

CAS No.: 171179-06-9

PD158780 (PD-158780)

Catalog No.: PC-45479Not For Human Use, Lab Use Only.

PD158780 is a highly potent, selective, ATP binding site inhibitor of EGFR with IC50 of 8 nM.

Packing Price Stock Quantity
10 mg $118 In stock
25 mg $198 In stock
50 mg $328 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

PD158780 is a highly potent, selective, ATP binding site inhibitor of EGFR with IC50 of 8 nM.
PD158780 inhibits EGFR autophosphorylation in A431 human epidermoid carcinoma cells (IC50=15 nM).
PD158780 potently inhibits the LPA-stimulated MKK1/2 activation and EGFR phosphorylation in HeLa cells.
PD158780 also inhibits the kinase activity of ACK-1 in vitro (IC50=200 nM), inhibits the growth of v-Ha-Ras-transformed NIH 3T3 cells.

Physicochemical Properties

M.Wt 330.1826
Formula C14H12BrN5
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Pyrido[3,4-d]pyrimidine-4,6-diamine, N4-(3-bromophenyl)-N6-methyl-

References

1. Rewcastle GW, et al. J Med Chem. 1996 Apr 26;39(9):1823-35.

2. Cunnick JM, et al. J Biol Chem. 1998 Jun 5;273(23):14468-75.

3. Nur-E-Kamal A, et al. Mol Cancer Res. 2005 May;3(5):297-305.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: